Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > New info an plaque removal
View:
Comment by M101 on Apr 17, 2023 12:17pm
They have a hammer, problem must be a nail.  "No matter the antibody, removing large amounts of plaque seems to be key for nudging other biomarkers back toward healthier values." But at least they're pushing biomarkers, for now we can all milk the same cow.   
Comment by Gbathat on Apr 17, 2023 8:15pm
is it just me or are these articles trying to correlate plaque removal with improved health outcomes? Just wait til they finally catch up and learn that plaque clearance is just a side effect of these not-fully targeted drugs that are actually improving health outcomes by removing toxic oligomers of amyloid beta, not plaques And plaque removal actually has drawbacks wrt ARIA E And then wait til ...more  
Comment by G1945V on Apr 18, 2023 10:07am
My understanding has been that reduction in amyloid levels in the brain does not substantially improve cognition. The two articles as per my understanding seem to have changed that theory. ??? G1945V
Comment by Gbathat on Apr 18, 2023 11:15pm
I'm with you on the ???    correlation does not equal causation broadening the number of studies considered... https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905687/   
Comment by M101 on Apr 18, 2023 11:43pm
Thanks for that link. Of course it's not disinformation if it's propaganda, First Amendment under SCOTUS guarantees the right to buy your truth.    
Comment by M101 on Apr 18, 2023 11:43am
It's not just you Gbathat, there is an overton window at Alzforum, IMO that is its raison d'etre. I don't blame Azforum for this, it happens everywhere in every field where oligarchs saturate all media channels.  So we're going to continue to get 1000 words about some hypothetical silver lining to big pharma failures for every one word about cutting edge progress from ...more  
Comment by Gbathat on Apr 17, 2023 8:16pm
Also, thanks for sharing these and other insightful articles.  Much appreciated.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities